Anteris Technologies Global (NASDAQ: AVR) recently received a number of ratings updates from brokerages and research firms:
- 1/8/2025 – Anteris Technologies Global is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $20.00 price target on the stock.
- 1/7/2025 – Anteris Technologies Global is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $9.00 price target on the stock.
- 1/7/2025 – Anteris Technologies Global is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $22.00 price target on the stock.
- 1/7/2025 – Anteris Technologies Global is now covered by analysts at TD Cowen. They set a “buy” rating and a $15.00 price target on the stock.
Anteris Technologies Global Price Performance
Anteris Technologies Global stock traded down $0.12 during mid-day trading on Wednesday, reaching $5.63. The stock had a trading volume of 155,509 shares, compared to its average volume of 172,322. Anteris Technologies Global Corp has a fifty-two week low of $5.10 and a fifty-two week high of $6.00.
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Stories
- Five stocks we like better than Anteris Technologies Global
- How to Calculate Inflation Rate
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Industrial Products Stocks Investing
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Pros And Cons Of Monthly Dividend Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Anteris Technologies Global Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global Corp and related companies with MarketBeat.com's FREE daily email newsletter.